|
EIF2B2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00010000281259E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.88309999710401E-08 |
| Normal-vs-Stage2 |
8.390000E-01 |
| Normal-vs-Stage3 |
8.50239989524937E-10 |
| Normal-vs-Stage4 |
1.6304735339645E-12 |
| Stage1-vs-Stage2 |
1.127500E-02 |
| Stage1-vs-Stage3 |
6.127900E-02 |
| Stage1-vs-Stage4 |
1.6293700000003E-05 |
| Stage2-vs-Stage3 |
1.544430E-03 |
| Stage2-vs-Stage4 |
8.42500000000079E-05 |
| Stage3-vs-Stage4 |
3.661700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.81720022047239E-10 |
| Normal-vs-AfricanAmerican |
1.901960E-02 |
| Normal-vs-Asian |
7.42219619098705E-11 |
| Caucasian-vs-AfricanAmerican |
8.100800E-01 |
| Caucasian-vs-Asian |
1.033760E-01 |
| AfricanAmerican-vs-Asian |
4.121400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.43639999894418E-08 |
| Normal-vs-Female |
1.1020000001416E-07 |
| Male-vs-Female |
2.277400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.27290005997361E-10 |
| Normal-vs-Age(41-60Yrs) |
5.07199999777441E-08 |
| Normal-vs-Age(61-80Yrs) |
2.379900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.504000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.439800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.301500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.839400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.634360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.988400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.387200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.4306000000186E-06 |
| Classical-VS-Follicular |
2.37940000036296E-07 |
| Classical-VS-Other |
9.557000E-01 |
| Classical-VS-Normal |
1.96660465690002E-11 |
| Tall-VS-Follicular |
4.11237710551404E-12 |
| Tall-VS-Other |
2.765000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.138430E-01 |
| Follicular-VS-Normal |
7.484200E-01 |
| Other-VS-Normal |
6.195300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.980600E-04 |
| Normal-vs-N1 |
9.99200722162641E-16 |
| N0-vs-N1 |
1.87819999553085E-08 |
|
|
